Cytoo's Motility Product Launch - Exclusive Offer at American Society for Cell Biology, December 15 -19, 2012
Published: Dec 10, 2012
The new product is based on CYTOO’s 2D+ Cell Culture Platform of 24 and 96-well plates that employ standard and custom adhesive micropatterns to guide cell architecture and behavior in culture.
By defining the 2D topology of cell adhesion, the 2D+ Cell Culture Platform enables fine control of the spreading and 3D shape of cultured cells in single- or multi-cellular configurations. This approach results in control of cell contractility, cell polarity, organelle positioning, and cell division axis. This technology addresses a major concern with traditional 2D culture, in which cells spread and move in an uncontrolled manner, introducing a considerable but unnoticed variability in cell function.
CYTOOplates Motility are specifically designed to study cell migration for screening applications in oncology and drug discovery, showing characteristics closer to those found in vivo1
“We will celebrate the first anniversary of the World Cell Race with the launch of our CYTOOplates Motility in a standard microplate format”, says Alexandra Fuchs, COO of CYTOO. “We have also seen our Motility products used in other application areas, such as directional neurite outgrowth assays.”
CYTOO’s Dr. Fuchs and Lisa Minor PhD, Application Development Leader, will be available at ASCB to present and discuss new application areas of the technology.
During ASCB 2012 meeting, CYTOO will offer 20% off all orders of Motility products. Attendees are invited to visit ASCB Booth #329 for this exclusive offer.
For more information, visit www.cytoo.com/ASCB2012
1. Sharma V, Beaty B, Patsialou A, et al. Reconstitution of in vivo macrophage-tumor cell pairing and streaming motility on one-dimensional micro-patterned substrates. IntraVital. 2012;1(1):77–85.
2. Maiuri P, Terriac E, Paul-Gilloteaux P, et al. The first World Cell Race. Curr Biol. 2012;22(17):R673–R675.
About CYTOO S.A.
CYTOO is a distinctive life sciences systems & tools company offering disruptive solutions for cell-based assays and High Content Screening (HCS) that reinforce robustness, sensitivity and powerful quantification. The Company’s 2D+ Cell Culture Platform, based on adhesive micropatterns, offers control over the cells' microenvironment, leading to normalized cell morphology and behavior. The technology allows the optimization or resurrection of complex or difficult cell-based assays and enables innovative assay development.
For more information about the complete product portfolio, visit www.cytoo.com